Europe Hematologic Malignancies Market Size & Outlook
The hematologic malignancies market in Europe is expected to reach a projected revenue of US$ 33,030.4 million by 2030. A compound annual growth rate of 7.6% is expected of Europe hematologic malignancies market from 2024 to 2030.
Revenue, 2023 (US$M)
$19,717.5
Forecast, 2030 (US$M)
$33,030.4
CAGR, 2024 - 2030
7.6%
Report Coverage
Europe
Europe hematologic malignancies market, 2018-2030 (US$M)
Europe hematologic malignancies market highlights
- The Europe hematologic malignancies market generated a revenue of USD 19,717.5 million in 2023.
- The market is expected to grow at a CAGR of 7.6% from 2024 to 2030.
- In terms of segment, leukemia was the largest revenue generating disease in 2023.
- Leukemia is the most lucrative disease segment registering the fastest growth during the forecast period.
Europe data book summary
| Market revenue in 2023 | USD 19,717.5 million |
| Market revenue in 2030 | USD 33,030.4 million |
| Growth rate | 7.6% (CAGR from 2023 to 2030) |
| Largest segment | Leukemia |
| Fastest growing segment | Leukemia |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Leukemia |
Other key industry trends
- In terms of revenue, Europe region accounted for 29.3% of the global hematologic malignancies market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 28,622.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Hematologic Malignancies Market Scope
Hematologic malignancies market segmentation & scope
Therapy
Chemotherapy
Immunotherapy
Targeted Therapy
Other Therapies
End Use
Hospital Pharmacies
Retail Pharmacies
Other
Countries
U.S.
Canada
Mexico
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Japan
China
India
Australia
South Korea
Thailand
Brazil
Argentina
South Africa
Saudi Arabia
UAE
Kuwait
Hematologic Malignancies Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe hematologic malignancies market
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
